Are IQ Option's Charts Rigged? The "Fake Charts" Myth

Where the "fake charts" belief comes from

Most rigging accusations start with a candle that looked different from another chart, or a position that closed a fraction of a point away from a win. Both have explanations that do not require fraud.

The belief is widespread, it is sincerely held, and it usually begins with one of four specific experiences. Naming them is the fastest way to work out which one applies to you.

The four origin stories

• The mismatched candle. A trader compares the platform chart against a free charting site and sees a different wick or a different close. The comparison is almost always between an OTC instrument and exchange data, which are two different products with two different prices.
• The one-point loss. A short-expiry position finishes marginally on the wrong side. On a compressed time horizon that outcome is common, and it is decided by spread and normal price noise rather than by anyone intervening.
• The weekend spike. Prices move on a Saturday when the underlying market is closed. This is expected on OTC instruments and impossible on exchange-traded ones, which is exactly why the OTC category exists.
• The losing streak after a winning demo run. The demo has no real slippage, no funding constraint and no emotional load, so a strategy that worked there frequently does not survive contact with a live account.

Why the accusation sticks

A broker that quotes its own prices has an interest in those quotes. That is a real conflict, and pretending it does not exist would be dishonest. It is also structural rather than secret: it is inherent to how OTC dealing works across the industry, it is described in product terms, and it is supervised. The accusation sticks because the conflict is genuine and the disclosure is buried in documents nobody reads, so the first time a trader encounters the concept is usually after a loss.

The role of expectation

There is also a psychological component worth naming without condescension. Short-expiry trading delivers outcomes fast, which means a trader accumulates a large sample of wins and losses in a single afternoon. Human pattern recognition is excellent at finding intent in noise, so a run of narrow losses reads as targeting rather than as variance. The same run on a slower timeframe would barely register. This does not make anyone gullible; it makes the product unusually good at generating suspicion, which is one more reason the disclosure around OTC pricing deserves to be prominent rather than buried in a terms document.

What would count as actual rigging

Manipulation, in the sense that would make this a fraud, means quotes that are moved to trigger client stop-outs or to decide expiries, on instruments whose pricing basis is not disclosed. The observable signature would be a persistent, one-directional divergence between the platform and independent references on non-OTC assets during market hours — not a single unfavourable tick. The price-manipulation page examines that claim on its own terms; this page is about the charts themselves.

Almost every "fake chart" report traces back to an OTC instrument, a very short expiry, or a closed underlying market — identify which one applies before drawing a conclusion.

How price data reaches the platform

Exchange-traded instruments derive from feeds tied to the underlying venue, while OTC instruments are priced by the broker from its own model. Which one you are trading determines what your chart should look like.

Before comparing anything, it helps to know what you are comparing. Retail platforms display two structurally different kinds of price, and they get confused constantly.

Why even matching feeds show small differences

• The spread. A chart may display mid, bid or ask. Comparing an ask-based platform chart to a mid-based public chart produces a constant offset that looks like a shifted price.
• Timing and aggregation. Feeds tick at different rates and aggregate candles slightly differently, which changes wicks far more than it changes closes.
• Time zone and session boundaries. A one-hour offset redraws every candle on the screen and is the most common cause of "the chart is wrong".
• Venue differences. Two data providers quoting the same instrument from different venues will not be identical either. This is not unique to brokers.

The honest disclosure

OTC pricing is a real structural difference and a real conflict of interest that any trust review should state rather than minimise. The regulatory answer is not that the conflict disappears; it is that a CySEC-supervised firm is required to have conflict-of-interest controls, and that those controls are examinable. Notably, conflict-of-interest safeguards were among the matters covered by the CySEC settlement dated 15 April 2019 — which tells you both that this area is genuinely sensitive and that it has been supervised.

Know whether your instrument is OTC before you compare charts, because the two categories are not supposed to produce the same picture.

OTC instruments versus exchange-traded markets

OTC products let you trade when exchanges are shut, at prices the broker sets. That convenience is the whole trade-off: no external reference, and a counterparty with an interest in the quote.

OTC instruments are priced by the broker from its own quote model rather than by an exchange, and they are typically the only instruments tradable when underlying markets are closed. Both halves of that sentence matter, and the second half is why the category is popular in the first place.

What you gain and what you give up

Practical consequences

1. Never use an OTC chart to prove or disprove manipulation. There is no independent reference, so the exercise cannot conclude anything.
2. Expect OTC and exchange prices for a nominally similar asset to diverge, particularly around market opens and closes.
3. Treat weekend trading as a distinct activity with its own risk profile rather than a continuation of the week.
4. If you want a verifiable price, trade a non-OTC instrument during its market hours.

Where OTC pricing sits in a fair review

Two positions get stated loudly and both are wrong. The first is that OTC pricing is proof of fraud, which ignores that the category is standard, labelled and supervised across the industry. The second is that the conflict is irrelevant because the firm is licensed, which ignores that a licence manages a conflict rather than removing it. The accurate position sits between them: you are trading a product where your counterparty sets the price, you should know that before you open the position, and you should keep the instruments you cannot verify to a share of your activity you are comfortable with.

The regulatory context

Digital options and CFDs sold to EU retail clients sit under ESMA and CySEC product intervention rules: capped leverage, tighter caps on volatile assets, mandatory negative balance protection, standardised risk warnings, and a ban on monetary inducements such as deposit bonuses. Binary options were banned outright for EU retail clients from 2018. None of that removes the OTC conflict of interest, but it does mean the products are sold inside a supervised framework where the firm's conflict controls are subject to inspection. The regulator record page collects those interventions.

OTC is a legitimate product category with a built-in conflict of interest, and it is the wrong surface on which to test whether a chart is honest.

Testing the rigging claim fairly

A fair test uses a non-OTC instrument during normal market hours, an independent chart from an unrelated source, matched time zones and matched price basis, observed over a session rather than a single tick.

The claim is testable, which is more than can be said for most trust-page arguments. Here is a method you can run without an account balance at risk, using the demo if you prefer.

The procedure

1. Pick a non-OTC instrument — a major currency pair or a widely followed index — and confirm from the instrument label that it is not the OTC variant.
2. Trade only within the underlying market's opening hours. Anything outside them invalidates the comparison.
3. Open an independent chart from a provider with no relationship to the broker, and set both to the same time zone.
4. Match the price basis and interval. Use the same candle interval, and note whether each chart shows bid, ask or mid — a fixed offset between them is the spread, not a manipulation.
5. Watch a full session, not a moment. Record the open, high, low and close of several candles rather than screenshotting one wick.
6. Look for direction in any divergence. Random small differences are feed noise. Differences that consistently move against open positions are the thing worth escalating.
7. Escalate through the proper channel. Raise a formal complaint with the firm, keep the timestamps and screenshots, and if the firm is the CySEC-licensed entity you can take an unresolved complaint to the regulator.

What the test cannot show

• Anything about OTC instruments, since no external reference exists.
• Anything from a single trade. One adverse expiry is noise by definition.
• Anything about execution speed or slippage, which need a different kind of evidence than a chart comparison.

A note on our own limits

This desk has not run this test on a funded account, and we are not going to claim otherwise. What we can do is give you a method that produces evidence rather than impressions, and be explicit that a screenshot of one losing trade is not evidence. If you follow the procedure and find a persistent, one-directional divergence on a non-OTC instrument during market hours, that is a substantive finding and it belongs in a formal complaint. Our complaints guide covers how to document and file one.

Test on a non-OTC instrument during market hours, over a full session, with matched settings — anything else produces a story rather than evidence.

An honest verdict on the charts

There is no documented finding that IQ Option fabricates its price feed. There is a real, disclosed OTC conflict of interest, and a supervised firm whose conflict controls have already been examined by its regulator.

Weighing what exists in the public record against what circulates in forum threads, the verdict is narrower than either side usually wants.

What the record supports

• No regulator finding that the firm fabricates price data has been established in the public record we reviewed.
• CySEC did settle with IQ Option Europe Ltd in a decision dated 15 April 2019, published 21 May 2019, for a reported EUR 450,000, covering possible breaches including conflict-of-interest safeguards, due diligence and transaction security. That is a compliance matter that has been resolved, not a finding of feed manipulation.
• The firm operates under a CySEC licence, 247/14, within the MiFID II framework, so its conflict-of-interest arrangements sit inside a supervised regime.

What the record does not support

It does not support the claim that candles are drawn to defeat individual traders, and it does not support the opposite claim that there is no conflict to worry about. A broker pricing its own OTC instruments has an interest in those prices, permanently. The defensible position is that this is a known, regulated structure with disclosed terms, not a hidden mechanism.

How this compares with the alternative

It is worth asking what the comparison set looks like. An unlicensed offshore platform quoting its own OTC prices has the identical conflict of interest, plus no supervisor examining its conflict controls, no segregation requirement, no compensation scheme and no complaints route that ends anywhere. The presence of a public settlement against a licensed firm is uncomfortable reading, but it is also the visible output of a system that has no equivalent on the offshore side. Weigh the two on that basis rather than on which website looks more confident.

What to actually do about it

1. Trade non-OTC instruments during market hours if independent verification matters to you.
2. Read the product terms for the instrument classification before you open a position, not after.
3. Keep expiries long enough that the outcome is not decided by the spread.
4. Use the practice account to learn the interface, while remembering the legitimate demo-to-live gap.
5. If something looks wrong, document it with timestamps and file a complaint rather than posting a screenshot.

The wider trust picture, including the licence, the coverage gap outside the EEA and the complaint patterns, is set out on our IQ Option scam or legit verdict. Regulatory details here were checked against public regulator records on 3 September 2026. Trading CFDs and leveraged products carries a high risk of losing money.

The charts are not the scandal people expect, but the OTC conflict of interest is real — trade the instruments you can verify and treat the rest accordingly.